Merck KGaA family says unreservedly behind the pharma unit
DARMSTADT, Germany (Reuters) - The family behind Germany's Merck KGaA said it was fully committed to the group's pharmaceuticals unit, even if cancer immunotherapy hopeful avelumab does not achieve blockbuster sales.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news
More News: Cancer | Cancer & Oncology | Germany Health | Health | Immunotherapy | Merck | Pharmaceuticals